CA2859934A1 — Hayley's comet ii

USPTO Abstract

A new cultivar of medical cannabis has been bred that renders relatively large amounts of cannabidiolic acid (mg/gram ground flower weight)...greater than 10%. The cultivar moved from an outdoor to indoor environment produced similar levels of cannabidiolic acid (CBD-A) and similar cannabinoid profiles. Reproduced asexually, the same (greater than 10%) cannabidiolic acid amounts were rendered and this remains constant crop to crop. THC levels do not change between 20 and 30% of that of the CBD-A concentration. High Pressure Liquid Chromatography (HPLC) determines cannabinoid profiles where the amounts of the three most abundant cannabinoids (tetrahydrocannabinol, cannabinol, and cannabidiol) and their acids are quantified. The cannabinoid profile relates directly to the physiological effects of the plant as a medicine. In addition, a genetic fingerprint of the strain has been generated using gel electrophoresis. Strains high in cannabidiolic acid are rare since breeding has favored the high THC strains for their psychoactive effects (recreational cannabis). Hayley's Comet II provides a unique cannabinoid profile containing large concentrations of CBA-A making it useful for medicaments for seizure disorder, pain and inflammation.